Abstract:Background: Clustered regularly interspaced short palindromic repeat (CRISPR) RNA-guided adaptive immune systems are found in prokaryotes to defend cells from foreign DNA. CRISPR Cas9 systems have been modified and employed as genome editing tools in wide ranging organisms. Here, we provide a detailed protocol to truncate genes in mammalian cells using CRISPR Cas9 editing. We describe custom donor vector construction using Gibson assembly with the commonly utilized pcDNA3 vector as the backbone. Results: We describe a step-by-step method to truncate genes of interest in mammalian cell lines using custom-made donor vectors. Our method employs 2 guide RNAs, mutant Cas9D10A nickase (Cas9 = CRISPR associated sequence 9), and a custom-made donor vector for homologous recombination to precisely truncate a gene of interest with a selectable neomycin resistance cassette (NPTII: Neomycin Phosphotransferase II). We provide a detailed protocol on how to design and construct a custom donor vector using Gibson assembly (and the commonly utilized pcDNA3 vector as the backbone) allowing researchers to obtain specific gene modifications of interest (gene truncation, gene deletion, epitope tagging or knock-in mutation). Selection of mutants in mammalian cell lines with G418 (Geneticin) combined with several screening methods: western blot analysis, polymerase chain reaction, and Sanger sequencing resulted in streamlined mutant isolation. Proof of principle experiments were done in several mammalian cell lines. Conclusions: Here we describe a detailed protocol to employ CRISPR Cas9 genome editing to truncate genes of interest using the commonly employed expression vector pcDNA3 as the backbone for the donor vector. Providing a detailed protocol for custom donor vector design and construction will enable researchers to develop unique genome editing tools. To date, detailed protocols for CRISPR Cas9 custom donor vector construction are limited (Lee et al. in Sci Rep 5:8572, 2015; Ma et al. in Sci Rep 4:4489, 2014). Custom donor vectors are commercially available, but can be expensive. Our goal is to share this protocol to aid researchers in performing genetic investigations that require custom donor vectors for specialized applications (specific gene truncations, knock-in mutations, and epitope tagging applications).

CRISPR/Cas9-Mediated Gene Knockout in Cells and Tissues Using Lentivirus.

A Robust Protocol for CRISPR‐Cas9 Gene Editing in Human Suspension Cell Lines

Efficient Gene Knockout in Salivary Gland Epithelial Explant Cultures

Establishing a dual knock-out cell line by lentivirus based combined CRISPR/Cas9 and Loxp/Cre system

Guide for generating single-cell-derived knockout clones in mammalian cell lines using the CRISPR/Cas9 system

Generating Single Cell–Derived Knockout Clones in Mammalian Cells with CRISPR/Cas9

A Simple and Low-Cost CRISPR/Cas9 Knockout System Widely Applicable to Insects

A protocol for custom CRISPR Cas9 donor vector construction to truncate genes in mammalian cells using pcDNA3 backbone

Multiplexed CRISPR/Cas9 gene knockout with simple crRNA:tracrRNA co-transfection

A High-Throughput Microdroplet-Based Single Cell Transfection Method for Gene Knockout Based on the CRISPR/Cas9 System

Abstract 5607: A highly efficient donor system for CRISPR knock-in editing

User-Friendly Genetic Conditional Knockout Strategies by CRISPR/Cas9

A robust method for protein depletion based on gene editing

Protocol: Genome-scale CRISPR-Cas9 Knockout and Transcriptional Activation Screening

An Efficient and Precise Method for Generating Knockout Cell Lines Based on CRISPR‐Cas9 System

CRISPRs for Optimal Targeting: Delivery of CRISPR Components as DNA, RNA, and Protein into Cultured Cells and Single-Cell Embryos

In Silico Design of gRNA for CRISPR/Cas9-Mediated Gene Knockout

Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening

An improved strategy for CRISPR/Cas9 gene knockout and subsequent wildtype and mutant gene rescue

Lentivirus pre-packed with Cas9 protein for safer gene editing

A simple, rapid, and efficient method for generating multigene-knockout culture cells by the CRISPR/Cas9 system